Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
批准号:
10658408
负责人:
ALEC J HIRSCH
金额:
$23.1万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-15 至 2025-02-28
关键词:
3&apos Untranslated RegionsAccelerationAgeAge MonthsAllelesAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloid beta-ProteinAmyloid beta-Protein PrecursorAnimalsAnti-Inflammatory AgentsAntiinflammatory EffectApolipoprotein EArctic mutationAttenuatedBehavioralBindingBinding ProteinsBody TemperatureBrainCapsid ProteinsCellsCentenarianCerebrumChickenpoxCholesterol HomeostasisCircadian RhythmsCognitiveCommunicable DiseasesDNA MethylationDengue VirusDisease ProgressionDoseEpisodic memoryEuthanasiaExposure toFlavivirusGenesGeneticGenomicsHIV-1Hepatitis C virusHepatitis E virusHerpes zoster diseaseHerpesvirus 1HippocampusHomeostasisHumanHuman Amyloid Precursor ProteinHuman Herpesvirus 4Impaired cognitionImpairmentInfectionInflammationInflammatoryInjuryInterferonsInterleukinsKlebsiella pneumoniaeKnock-inKnock-in MouseLate Onset Alzheimer DiseaseLearningLipidsLong-Term EffectsMacrophageMalariaMeasuresMicrogliaMusNerve DegenerationNeurodegenerative DisordersPathogenesisPatientsPeptidesPerformancePilot ProjectsPlasmaPlayPredispositionPresynaptic TerminalsProcessProductionPromoter RegionsProtein IsoformsPurkinje CellsReportingRiskRisk FactorsRoleSenile PlaquesStimulusSynapsesTemperatureTestingTimeUp-RegulationVery low density lipoproteinViral GenomeVirusVirus DiseasesVirus InhibitorsWest Nile viral infectionWest Nile virusWild Type Mouseage effectage related neurodegenerationamyloid peptideapolipoprotein E-3apolipoprotein E-4behavioral phenotypingchemokinecognitive performancecohortcytokineentorhinal cortexglial activationhippocampal atrophyhuman modelimprovedmiddle agemillimetermixed dementiamouse modelnervous system disorderneuroinflammationneuron lossneuropathologyneurotropicnew therapeutic targetnovelnovel markernovel therapeutic interventionresponsesensorsynucleintargeted treatmentuptakewireless
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
West Nile Virus (WNV) can cause severe and long-lasting neurological disease. Initial infection in the
hippocampus results in some of the neuropathology and neuroinflammation seen in Alzheimer's disease (AD).
There are three human apolipoprotein E (E) isoforms, which play a role in cholesterol metabolism: E2, E3, and
E4. Compared to E3, E2 is protective with regard to AD risk, while E4 is an AD risk factor. E4 is also associated
with enhanced entry of human immunodeficiency virus 1 (HIV-1) cell entry and HIV-1 disease progression. E
an
susceptibility
varicella
is
HIV-1-inducible inhibitor of viral production and infectivity in macrophages, involved i n the pathogenesis and
to other infectious diseases, including herpes simplex virus-1, hepatitis C virus, hepatitis E virus,
zoster virus, Epstein-Barr virus, malaria, (LM), andListeria monocytogenes Klebsiella pneumoniae. In
a mouse model of herpes simplex virus 1 (HSV-1), the cerebral load of latent HSV-1 genomic copies, which is
associated with the reactivation risk, is 10-fold higher in E4 than E3 mice. These apoE isoform differences might
involve very low-density lipoproteins (VLDL), as E4 binds better than E3 to VLDL and impairs their lipolytic
processing. WNV capsid protein binds VLDL, as does Dengue virus capsid protein and is thought to be important
for uptake and transport of virus. The differential interactions of apoE isoforms with human amyloid precursor
protein (APP) and with the amyloid peptides A40 and A42 generated from APP might influence cognitive injury
and neurodegeneration. APP, A40 and A42 might be important in viral infections as well and AD patients might
have an altered susceptibility to viral infections. We crossed APP NL-G-F mice with human apoE targeted
replacement (TR) mice and will use these mice for the proposed study. The hippocampus shows neuropathology
in brains of WNV patients and C57BL/6J wild-type mice infected with an attenuated WNV strain show spatial
learning impairments associated with interleukin 34 (IL-34)-dependent engulfment of presynaptic terminals by
activated microglia in the hippocampus during and after viral infection. We will determine whether prior exposure
to WNV worsens hAPP/A-induced behavioral alterations and cognitive impairments and neuropathology in 6-
and 12-month-old hAPP KI mice in an apoE isoform-dependent fashion, and whether these effects are
associated with enhanced neuroinflammation and microglial activation. We include novel wireless temperature
sensors to analyze body temperature and circadian rhythms following WNV exposure and as a function of
hAPP/A apoE isoform, and age. We will also assess cytokines and chemokines in plasma and brain.
Neuroinflammation, neuron loss and upregulation of APP and Aβ are not specific to AD and/or WNV infection.
While there is significant overlap between WNV and neurodegeneration pathogenesis, this has been understudied
and it is important to increase our understanding about the similarities as this will facilitate the identification of
novel biomarkers and therapeutic strategies for AD and other neurodegenerative disorders. This proposal is
submitted in response to PAR-22-094 and NOT-AG-21-039.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Virus-Like Particle Vaccine for Powassan Virus
-
批准号:10407602
-
项目类别:
-
资助金额:$52.3万
-
财政年份:2020
-
负责人:ALEC J HIRSCH
-
依托单位:
Development of a Virus-Like Particle Vaccine for Powassan Virus
-
批准号:10176399
-
项目类别:
-
资助金额:$50.04万
-
财政年份:2020
-
负责人:ALEC J HIRSCH
-
依托单位:
Development of a Virus-Like Particle Vaccine for Powassan Virus
-
批准号:10674086
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2020
-
负责人:ALEC J HIRSCH
-
依托单位:
Development of a Virus-Like Particle Vaccine for Powassan Virus
-
批准号:10636646
-
项目类别:
-
资助金额:$53.27万
-
财政年份:2020
-
负责人:ALEC J HIRSCH
-
依托单位:
Evaluation of Host miRNAs as Therapeutics against Encephalitogenic Flaviviruses
-
批准号:8366468
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2012
-
负责人:ALEC J HIRSCH
-
依托单位:
Evaluation of Host miRNAs as Therapeutics against Encephalitogenic Flaviviruses
-
批准号:8471055
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2012
-
负责人:ALEC J HIRSCH
-
依托单位:
海外基金